International Patients
Pourquoi nous choisir?
ELZA, une combinaison unique de chirurgiens hautement qualifiés, de physiciennes, et de chercheurs. Ensemble, ils garantissent un traitement optimal.
APPRENEZ PLUS
لماذا نحن؟
مؤسسة «الزا» في سويسرا تضم نخبة مميزة من اطباء عيون متمرسين, فيزيائيين, وباحثين, لكي تزودك بالعلاج الامثل.
اعرف اكثر
با انتخاب ما از چه مزایایی می توانید بهره مند شوید؟
موسسه الزا در کشور سوئیس شامل مجموعه ای از متبحترین چشم پزشکان، متخصصان فیزیک و پژوهشگران می باشد تا بهترین راه حل را برای درمان مشکل شما فراهم نمایند.
طلاعات بیشتر
Почему Вам лучше выбрать нас?
ELZA Institute в Швейцарии – это уникальное сочетание высококвалифицированных офтальмологов, физиков и научных исследователей, которые готовы предоставить Вам самoе лучшее лечение.
УЗНАЙТЕ БОЛЬШЕ
Latest News
ELZA’s Surgeons on the Podium and in the News
Podium Power: Dion Paridaens gives three ESASO oculoplasty lectures in Lugano For the second year in a row, Dr. Dr. Dion Paridaens gave a series of lectures at the 2019 ESASO ...
Read More
Read More
Awards and Distinctions
Given to ELZA members in the past 20 years for their contributions in ophthalmology.
ELZA’s Surgeons on the Podium and in the News
Podium Power: Dion Paridaens gives three ESASO oculoplasty lectures in Lugano For the second year in a row, Dr. Dr. Dion Paridaens gave a series of lectures at the 2019 ESASO ...
Read More
Read More
Scientific
Our research laboratory at the University of Zurich
The ELZA co-founder Prof. Farhad Hafezi is running a research laboratory at the University of Zurich, Switzerland. The main foci are corneal biomechanics (keratoconus) and ocular cell biology.
Visit the CABMM’s website here.
Educational
We proudly announce that the second edition of our medical textbook “Corneal Cross-Linking” will soon appear with Slack Inc. The book is edited by ELZA Founder Farhad Hafezi (University of Geneva & USC Los Angeles) and J. Bradley Randleman (USC Los Angeles). It is the oldest and most complete international textbook on cross-linking technology.
Humanitarian
Our International humanitarian initiative
To increase awareness about keratoconus in children.
To disseminate information amongst parents and children.
To treat children with keratoconus in National Reference Sites.
To perform research to identify the causes of keratoconus.
Visit the Light for Sight website here.
Entrepreneurial
ELZA in the global „Top 40 under 40“
We are proud to announce that our co-founder and head of Strategy and BD&L, Nikki Hafezi, MASIP ETHZ, was voted by her peers among the Top 40 under 40 in the British journal „The Ophthalmologist. This list comprises „the most important upcoming personalities in global opthalmology„.
Mrs Hafezi also serves as CEO of EMAGine SA.
See the online version of the PowerList „Top 40 under 40“ here, and read the PDF here.
Developing the future of Cross-Linking Technology
ELZA members co-founded a Spin-Off Company: EMAGine SA.
EMAGine SA develops a cross-linking device that will fit on a slit lamp.
The device will allow for treatment outside an operating theatre.
Visit EMAGine’s website here.
ELZA Posts
ELZA’s Surgeons on the Podium and in the News
Podium Power: Dion Paridaens gives three ESASO oculoplasty lectures in Lugano For the second year in a row, Dr. Dr. Dion ...
More...
More...
Cross-Linking in the USA – Part 3: Off-Label applications
Cross-Linking: Off-label applications Epi-off CXL Cross-linking the cornea isn’t without drawbacks. Thanks to the need to remove the central 9 ...
More...
More...
Cross-Linking in the USA – Part 4: The Future
PACK-CXL The process of cross-linking the cornea involves two important antimicrobial actions. The first is a direct, pathogen killing effect: ...
More...
More...
Cross-Linking in the USA – Part 2: Best Practice
Follow best-practice Anaesthesia Topical, usually with tetracaine or proparacaine, although children and non-cooperative patients may require alternative forms of anaesthesia ...
More...
More...
Cross-Linking in the USA – Part 1: Patient and Riboflavin Selection
Cross-Linking in the USA Corneal cross-linking (CXL) in the USA is a relatively recent phenomenon, although it’s a technique that ...
More...
More...
Farhad Hafezi on being appointed FARVO
Being appointed FARVO – Fellow of the Association for Research in Vision and Ophthalmology – is a big deal for ...
More...
More...
